Get started
Author

Zuoyi Shao

Observed name: Shao, Zuoyi
OpenAlex ID: A5132865358
PA-130 Dasatinib and Quercetin in Patients with Relapsed, Refractory Multiple Myeloma Receiving CAR-T Therapy: First Report from the Safety Run-in of the Phase II DART Trial
2026 · Christoph Schaefers, Melinda Tan, et al. · Clinical Lymphoma Myeloma & Leukemia
Abstract 1213: Mitochondrial transcriptome profiles associated with clinical responses to CAR-T therapy in aggressive lymphoma.
2026 · Jacqueline Turner, Panwen Wang, et al. · Cancer Research
Abstract 3278: Metabolic pathway signatures defining response to CD19 CAR T-Cell therapy in aggressive B-cell non-hodgkin lymphoma
2026 · Melinda S.Y. Tan, Panwen Wang, et al. · Cancer Research
Abstract 7935: Multimodal immunotherapy remodels the tumor microenvironment in hepatocellular carcinoma: Integrative spatial and transcriptomic profiling from a Phase II trial
2026 · Lionel Aurelien Kankeu Fonkoua, Christopher L. Hallemeier, et al. · Cancer Research
Abstract 6475: Myeloma cells with therapy-induced senescence-like phenotype have increased resistance to killing by T cell directed therapies
2026 · Christoph Schaefers, Angelo Jose Guilatco, et al. · Cancer Research
Abstract 6467: Myeloma cells with therapy-induced senescence-like phenotype are associated with resistance to CAR-T therapy
2026 · Sofia Arbelaez, Andre De Menezes Silva Corraes, et al. · Cancer Research
Abstract 3931: Immune cell profile changes in patients treated with tarlatamab for extensive stage small cell lung cancer in real world practice.
2026 · Dhauna Karam Prasad, Andre De Menezes Silva Corraes, et al. · Cancer Research
Abstract 5198: A non-viral mRNA engineering platform for rapid, same-day immune-cell therapies
2026 · Chen Wu, Christoph Schaefers, et al. · Cancer Research
Abstract 3741: Radiation-dendritic cell combination therapy drives systemic cellular immune shifts in liver cancer
2026 · Melody Wu, Panwen Wang, et al. · Cancer Research
Works count: 12
Citation count:
H-index:
I10-index:
Year
Topic
Type